Patents by Inventor Sanjay Wagh

Sanjay Wagh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymers including galactose based blocks and uses thereof
    Patent number: 11396571
    Abstract: Block copolymers that include one or more galactose based blocks and one or more cationic blocks; polyplexes including disclosed block copolymers and one or more nucleic acids; and methods of delivering a nucleic acid to a cell which can include delivering a polyplex to the cell.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: July 26, 2022
    Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Theresa M. Reineke, Yogesh Khemchandra Dhande, Bharat Sanjay Wagh
  • POLYMERS INCLUDING GALACTOSE BASED BLOCKS AND USES THEREOF
    Publication number: 20160346395
    Abstract: Block copolymers that include one or more galactose based blocks and one or more cationic blocks; polyplexes including disclosed block copolymers and one or more nucleic acids; and methods of delivering a nucleic acid to a cell which can include delivering a polyplex to the cell.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 1, 2016
    Inventors: Theresa M. Reineke, Yogesh Khemchandra Dhande, Bharat Sanjay Wagh
  • Pharmaceutical formulation of cefixime for enhanced bioavailability
    Patent number: 9149482
    Abstract: A chewable tablet comprising Cefixime having a mean particle size between 20? and 120? wherein the said composition demonstrates bioequivalence to a suspension of Cefixime trihydrate. The process of preparation of the chewable tablet comprises the steps of optionally micronizing Cefixime such that the mean particle size of the Cefixime particles is between 20? and 120?, blending with other excipients, roll compaction, milling to form granules, blending to form a secondary blend and compression of the secondary blend to form tablets.
    Type: Grant
    Filed: May 10, 2004
    Date of Patent: October 6, 2015
    Assignee: Lupin Ltd.
    Inventors: Sanjay Wagh, Hidaytulla Aga, Makarand Avachat, Himadri Sen
  • NOVEL PHARMACEUTICAL FORMULATION OF CEFIXIME FOR ENHANCED BIOAVAILABILITY
    Publication number: 20140171401
    Abstract: A chewable tablet comprising Cefixime having a mean particle size between 20? and 120? wherein the said composition demonstrates bioequivalence to a suspension of Cefixime trihydrate. The process of preparation of the chewable tablet comprises the steps of optionally micronizing Cefixime such that the mean particle size of the Cefixime particles is between 20? and 120?, blending with other excipients, roll compaction, milling to form granules, blending to form a secondary blend and compression of the secondary blend to form tablets.
    Type: Application
    Filed: February 24, 2014
    Publication date: June 19, 2014
    Applicant: LUPIN LTD.
    Inventors: Sanjay WAGH, Hidaytulla AGA, Makarand AVACHAT, Himadri SEN
  • Novel Extended Release Composition of Venlafaxine Hydrochloride Containing Polyvinyl Acetate
    Publication number: 20070292500
    Abstract: Extended release pharmaceutical composition of Venlafaxine hydrochloride comprising a pharmaceutically acceptable capsule containing minitablets. The minitablets comprise from about 20% to about 70% by weight effective amount of Venlafaxine hydrochloride, polyvinyl acetate, one or more pharmaceutically acceptable excipients. The minitablets have diameter from about 1 mm to 5 mm and are coated with a release controlling composition.
    Type: Application
    Filed: May 21, 2004
    Publication date: December 20, 2007
    Applicant: LUPIN LTD.
    Inventors: Sanjay Wagh, Hidaytulla Aga, Himadri Sen
  • Novel Pharmaceutical Formulation of Cefixime for Enhanced Bioavailability
    Publication number: 20070286901
    Abstract: A chewable tablet comprising Cefixime having a mean particle size between 20 ? and 120 ? wherein the said composition demonstrates bioequivalence to a suspension of Cefixime trihydrate. The process of preparation of the chewable tablet comprises the steps of optionally micronizing Cefixime such that the mean particle size of the Cefixime particles is between 20 ? and 120 ?, blending with other excipients, roll compaction, milling to form granules, blending to form a secondary blend and compression of the secondary blend to form tablets.
    Type: Application
    Filed: May 10, 2004
    Publication date: December 13, 2007
    Applicant: Lupin Ltd.
    Inventors: Sanjay Wagh, Hidaytulla Aga, Makarand Avachat, Himadri Sen
  • Stable bioavailable crystalline form of cefdinir and a process for the preparation thereof
    Publication number: 20060149056
    Abstract: The present invention relates to a stable and bioavailable crystalline form of a third generation cephalosporin antibiotic, cefdinir and a process for the preparation thereof. The present invention also relates to a pharmaceutical composition containing the novel crystalline cefdinir, useful in the treatment of maladies such as bacterial infections.
    Type: Application
    Filed: March 2, 2006
    Publication date: July 6, 2006
    Applicant: LUPIN LTD
    Inventors: Girij Singh, Himadri Sen, Dhananjai Srivastava, Himanshu Godbole, Gurvinder Singh, Pravin Mahajan, Umesh Rananaware, Sagar Nehate, Sanjay Wagh
  • Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
    Publication number: 20050245738
    Abstract: The present invention relates to a stable and bioavailable crystalline form of a third generation cephalosporin antibiotic, cefdinir and a process for the preparation thereof. The present invention also relates to a pharmaceutical composition containing the novel crystalline cefdinir, useful in the treatment of maladies such as bacterial infections.
    Type: Application
    Filed: May 3, 2004
    Publication date: November 3, 2005
    Applicant: LUPIN LTD
    Inventors: Girij Singh, Himadri Sen, Dhananjai Srivastava, Himanshu Godbole, Gurvinder Singh, Pravin Mahajan, Umesh Rananaware, Sagar Nehate, Sanjay Wagh